Purchase Order 75N91024P00409
Award Date
5/1/24
Potential Completion Date
9/30/24
Potential Value
$15K
Federal Agency
National Cancer Institute
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,182.40 firm fixed price delivery order is for gene synthesis services. Genscript specializes in providing customized DNA, antibodies, proteins, peptides, and other molecular biology products and services to support biomedical research and public health initiatives...
This firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company, has a potential value of $8,163.25. The award is for peptide services and does not have a set-aside designation. Genscript is a provider of gene synthesis, gene editing, protein production, and other molecular biology services to various federal agencies, including the NIH, CDC, FDA, and...
This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, was issued by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $4,217.03 firm fixed-price delivery order is for peptide services and does not have a set-aside designation. Genscript is a major provider of molecular biology products and services to federal agencies, including the NIH, Centers...
This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...
This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $5,353.40 firm fixed price delivery order is for peptide services and was completed on September 9, 2015. The contract has no set-aside designation. Genscript is a supplier of various products and services to federal agencies, including gene synthesis, gene editing, custom protein and antibody production, and...
This is a $3,078,000.00 firm fixed-price contract awarded by the National Cancer Institute (NCI) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of gene synthesis, peptide synthesis, and quality control analysis services to support the NCI Surgery Branch's clinical research efforts on mutation-reactive T-cells for the treatment of metastatic cancers. The contract has a 12-month base period with two 12-month option periods. There...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
This federal contract award is to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, for $3,903.76. The contract is a delivery order with a firm fixed price, awarded by the National Cancer Institute, which is a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract is for "Peptide Services" and does not have a set-aside designation. Genscript, a for-profit organization, has received...